ActRO Balance Sheet Health
Financial Health criteria checks 6/6
ActRO has a total shareholder equity of ₩70.8B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩107.3B and ₩36.5B respectively. ActRO's EBIT is ₩3.9B making its interest coverage ratio -6. It has cash and short-term investments of ₩31.2B.
Key information
0%
Debt to equity ratio
₩0
Debt
Interest coverage ratio | -6x |
Cash | ₩31.16b |
Equity | ₩70.76b |
Total liabilities | ₩36.49b |
Total assets | ₩107.25b |
Recent financial health updates
No updates
Recent updates
Not Many Are Piling Into ActRO Co., Ltd (KOSDAQ:290740) Just Yet
Dec 09Returns On Capital At ActRO (KOSDAQ:290740) Paint A Concerning Picture
Aug 12Shareholders Will Be Pleased With The Quality of ActRO's (KOSDAQ:290740) Earnings
Mar 25Could ActRO Co., Ltd (KOSDAQ:290740) Have The Makings Of Another Dividend Aristocrat?
Mar 10ActRO Co., Ltd's (KOSDAQ:290740) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Feb 04Will ActRO (KOSDAQ:290740) Multiply In Value Going Forward?
Jan 20What Does ActRO Co., Ltd's (KOSDAQ:290740) Share Price Indicate?
Jan 05What Type Of Returns Would ActRO's(KOSDAQ:290740) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Dec 23Is ActRO Co., Ltd (KOSDAQ:290740) A Smart Choice For Dividend Investors?
Dec 10We're Not So Sure You Should Rely on ActRO's (KOSDAQ:290740) Statutory Earnings
Nov 25Financial Position Analysis
Short Term Liabilities: A290740's short term assets (₩54.4B) exceed its short term liabilities (₩33.0B).
Long Term Liabilities: A290740's short term assets (₩54.4B) exceed its long term liabilities (₩3.5B).
Debt to Equity History and Analysis
Debt Level: A290740 is debt free.
Reducing Debt: A290740 has no debt compared to 5 years ago when its debt to equity ratio was 1.6%.
Debt Coverage: A290740 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A290740 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 23:25 |
End of Day Share Price | 2024/12/26 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ActRO Co., Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kwang Jin Kim | Cape Investment & Securities Co., Ltd. |
Jongsun Park | Eugene Investment & Securities Co Ltd. |
Sang-Hun Lee | iM Securities |